Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Ex dividend NOK 3.25 today

The shares in Atea ASA will be traded ex dividend NOK 3.25 as from today, 21.10.2016. For further information, please contact:Steinar Sønsteby, CEO Atea ASA, mobile (+47) 930 55 655Robert Giori, CFO Atea ASA, mobile (+47) 934 09 188   About AteaAtea is the leading supplier of IT infrastructure and system integration in the Nordic and Baltic regions with 6,800 employees. Atea is present in 89 cities in Norway, Sweden, Denmark, Finland, Lithuania, Latvia and Estonia. Atea delivers IT products from leading vendors and assists its customers with specialist competencies within IT

NeuroVive and Arbutus sign termination agreement

Lund, Sweden, October 21, 2016 - NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF), the mitochondrial medicine company, today announces that the license agreement with Arbutus Biopharma (formerly OnCore Biopharma, Inc.) has been terminated and all rights to the NVP018 compound have been reverted back to NeuroVive. The agreement, signed in 2014, was related to the development and commercialization of NeuroVive’s compound NVP018 for oral treatment of Hepatitis B viral infection.In its portfolio of several Hepatitis B compounds, Arbutus has previously made the decision to

Nomination Committee appointed ahead of Evolution’s 2017 AGM

The members of the Nomination Committee in preparation for Evolution’s 2017 Annual General Meeting have been appointed.In accordance with the resolution of the Annual General Meeting, the largest shareholders in the company as per the last business day of August who wish to appoint a representative shall appoint the Nomination Committee. In addition, the Chairman of the Board shall be a member of the Nomination Committee. Unless the members agree otherwise, the member who represents the largest shareholder in terms of votes will chair the Nomination Committee. The Nomination Committee

Cox Media Group expands its agreement with Cxense

Oslo, Norway – 21 October 2016 – Cxense ASA (OSE: CXENSE) today announced that Cox Media Group has expanded its agreement with Cxense to include video solutions.Cox Media Group (CMG), a subsidiary of American conglomerate Cox Enterprises, currently includes 14 broadcast television stations and one local cable channel, 59 radio stations, seven daily newspapers, and more than a dozen non-daily publications, as well as more than 100 digital services.  CMG currently operates in more than 20 media markets and reaches approximately 52 million Americans weekly, including more than 31 million TV

Alma Media's Q3 Interim Report to be published on 28 October 2016

Alma Media Corporation         Stock Exchange Release         21 October 2016 at 9.30 a.m. (EEST) ALMA MEDIA'S Q3 INTERIM REPORT TO BE PUBLISHED ON 28 OCTOBER 2016 Alma Media Corporation will publish its Interim Report for January–September 2016 on Friday, 28 October 2016 approximately at 9.00 EEST. A conference for Finnish media, investors and analysts will be held on the same day at 11.00–12.00 EEST in the Alma House (address: Alvar Aallon katu 3 C, Helsinki). In addition to the presentations held by President & CEO Kai Telanne and CFO Juha Nuutinen, participants will have an

Conference call interim report

Invitation to attend Vitrolife’s conference call regarding presentation of the interim report for the period January – September 2016. The presentation will be held in English.Time: Thursday November 3, 2016 at 10.00 a.m. CET. Registration can preferably be done 10-15 minutes before the conference start time on: Sweden dial in number: +46 (0)8 5052 0114  UK dial in number: +44 (0)207 1620 177  Conference name: Vitrolife, conference ID: 960496 Vitrolife participants:Thomas Axelsson, CEO Mikael Engblom, CFOThe press release for Vitrolife’s interim report will be released

Aker Solutions to Acquire Majority Stake in Brazil's C.S.E.

October 21, 2016 - Aker Solutions agreed to buy 70 percent of Brazilian C.S.E. Mecânica e Instrumentação Ltda, building on a strategy to expand its services business in key international markets. The agreement includes an option to purchase the remaining 30 percent of the company three years after the expected close of the transaction by the end of the first quarter of 2017. The parties agreed to not disclose the purchase price. The acquisition gives Aker Solutions access to Brazil's growing market for servicing existing oil and gas fields. C.S.E., which had revenue of BRL 322 million

Conference call on GHP’s Interim report January-September 2016

Invitation to attend GHP’s webcasted conference call regarding presentation of the Interim report January-September 2016.Time: Friday 28 October 2016 at 09.30 a.m. CET The conference call will be held in English and the webcast will be available at GHP’s website under Investor Relations or via the following link: GHP webcasted conference call Friday 28 October 2016  GHP’s CEO Daniel Öhman and Acting CFO Susanna Laursen will present the results and answer questions. To participate in the

Telephone conference in connection with Interim report

Collector AB (publ) will publish its report for the first nine months of 2016 on Monday 31 October around 08.15 (CET). A telephone conference with the opportunity to pose questions will be held at 10.00 (CET) am on the same day, with CEO Stefan Alexandersson, and CFO Pia-Lena Olofsson presenting the report.The telephone conference will be held in Swedish and streamed live on www.financialhearings.com . To join the telephone conference, please call: +46 8 5664 2694 or +44 20 3008 9802. The switchboard will open at 9.55 CET.  A recording of the telephone conference, including the

Notice of extraordinary general meeting in Platzer

NOTICE OF EXTRAORDINARY GENERAL MEETING IN PLATZER The shareholders of Platzer Fastigheter Holding AB (publ) are summoned to an extraordinary general meeting on Monday 14 November 2016 at 2 pm at Kilsgatan 4, Gothenburg, Sweden. Admission to the meeting is from 1.30 pm. RIGHT TO ATTEND Shareholders that wish to attend the general meeting must be entered in the shareholder register kept by Euroclear Sweden AB on 8 November 2016 and make notification of their intention to attend the meeting no later than on 8 November 2016, preferably before 4 p.m. The notification shall be sent

Volvo divests properties in Gothenburg

The Volvo Group has signed an agreement with the real estate company Platzer Fastigheter Holding AB regarding the sale of properties in the areas of Arendal, Torslanda and Säve in Gothenburg, Sweden. The sales price amounts to SEK 2.7 bn on a debt free basis and the divestment results in a capital gain of SEK 1.4 bn, which is expected to impact the Group’s operating income by the corresponding amount in the fourth quarter of 2016.The divestment is part of a long-term plan to gather the majority of Volvo Group office workers in Gothenburg in an area that will be called Campus Lundby. The

ECEX to construct 23-floor office complex in Vilnius

East Capital Explorer AB (publ) (“ECEX”) has, through a subsidiary, signed a long-term lease contract with Swedbank for premises covering approximately 70 percent of a new office building to be constructed in central Vilnius. The new building will be built on the land plot adjacent to the existing 3 Burės office complex, both of which were purchased by ECEX in 2014. ECEX will invest up to EUR 9m over a two-year construction period, which will commence in the fourth quarter 2016.Mia Jurke, CEO of East Capital Explorer, commented “This project reflects our long-term interest in commercial

Stable progress for ASSA ABLOY during the quarter

Third quarter · Sales totaled SEK 18,025 M (17,465), with 2% (3) organic growth and 2% (4) acquired growth · Strong growth for Global Technologies and Americas · Good growth for Entrance Systems and growth for EMEA · Negative growth for Asia Pacific due to weak demand in China · Trojan in the UK was acquired, with expected annual sales of SEK 220 M · Operating income (EBIT) was SEK 3,020 M (2,970). The operating margin was 16.8% (17.0) · Net income amounted to SEK 2,122 M (2,069) · Earnings per share amounted to SEK 1.91 (1.86) · Operating cash flow increased by

Tieto delivers Samsung Pay to Russian Standard Bank

A new payment solution provided by Tieto allows customers of Russian Standard Bank to use their Samsung Pay wallet when making purchases at any merchant with a MasterCard contactless POS terminal. This new solution supports both NFC (Near Field Communications) and MST (Magnetic Secure Transmission) technologies.Payments executed by customers of Russian Standard Bank is secured and ensured via Samsung KNOX – a built-in system for smartphones that protects against malicious attacks and continuously monitors possible vulnerabilities. The security of mobile payments is also reinforced by using

NICOCCINO SIGNS AGREEMENT WITH AN AMERICAN MANUFACTURER

In beginning of 2016, Nicoccino Holding AB took a new strategic direction with focus to license the Company’s unique nicotine strip. One main criteria to succeed with this drug classification is to identify a new producer. The Company has now signed an agreement with an American manufacturer who fulfills all regulatory requirements.  ”I am very happy that Nicoccino, after extensive efforts to secure a qualified partner, has finally signed an agreement with a producer that has deep knowledge and experience in develop and produce pharmaceuticals. We see that our partner has the flexibility

Come join us to hear more about our Nordic Entertainment & MTGx businesses

MTG will host a half day capital markets seminar on Thursday 10 November 2016 at Nio Rum, Hamngatan 2 in Stockholm. The event will feature presentations by members of the MTG executive management team and focus on the Group’s Nordic Entertainment and MTGx operations. Registration will be from 13.00, with presentations starting at 14.00 and finishing by 17.15, with an informal reception afterwards.Please email investors@mtg.com to register for the event by no later than Monday 31 October. The event will be webcast live on mtg.com and the link to the webcast and presentations will be made

IVISYS provides market update

Press releaseIVISYS AB556998-498121 October 2016 IVISYS AB (’IVISYS’) wishes to provide a market update to report information about the company's current situation, future and general progress. IVISYS is engaged in business development and currently has more than 40 offers out in the market, with a total value of more than 20 million SEK. The potential customers have operations of different sizes, and IVISYS believes that all the quotes will reach a conclusion within 12 months. About 10 new offers are presented to new prospects each month. IVISYS expects—as previously announced—to be

Platzer acquires property portfolio worth approximately SEK 2.8 billion from Volvo. Partially financed through a rights issue.

Platzer Fastigheter Holding AB (publ) (“Platzer” or “the Company”) has entered an agreement with AB Volvo, through Volvo Group Real Estate, on the acquisition of a property portfolio in Gothenburg. The underlying property value amounts to approximately SEK 2.8 billion and the acquired properties are estimated to have an annual rental value of approximately SEK 300 million. In order to finance part of the acquisition, Platzer’s board of directors has resolved, conditional on the general meeting’s approval, to carry out a new class B share issue of approximately SEK 700 million, with pre-

Interim Report, Januari – September 2016: Positive progress on a strong consulting market

”We’re in a really positive business cycle for the consulting sector. Ework expanded on a broad front, and our more recent initiatives in technology consulting, public sector assignments and our Polish operation performed positively.” Extract from CEO Zoran Covic’s commentary to the Interim Report.Third quarter 2016 compared to the corresponding period 2015 · Net sales increased by 25% to SEK 1,646 M (1,316). · Operating profit up by 10% to SEK 19.2 M (17.5). · Order intake amounted to SEK 1,864 M (1,453), a 28% increase. · Earnings per share after dilution were SEK 0.88 (0.

NPRO 3Q 2016: GROWTH IN RENTAL INCOME AND IMPROVED RESULTS

Rental income up  Overall rental income came to NOK 229.7 million, up from NOK 220.7 million in the same period of 2015. When purchase and sale of properties are taken into account, the increase in rental income was 10.1 per cent. Pre-tax profit of NOK 260.7 million After NOK 65 million in tax expense, net profit for the period came to NOK 195.7 million. That yielded ordinary earnings per share (EPS) of NOK 0.36 for the third quarter. Carried equity per share came to NOK 11.50 at 30 September 2016, up from NOK 11.20 at 30 June 2016 (Epra NAV: NOK 12.83 and Epra NNNAV: NOK 12.22 at

Improved operating profit and even clearer organic profile

JULY TO SEPTEMBER 2016 (THIRD QUARTER) · Net sales amounted to SEK 522 million (367). · Operating profit before depreciation/amortisation and impairment, EBITDA, amounted to SEK 42 million (31), before non-recurring items. · Profit for the period was SEK 7 million (39), corresponding to earnings per share, before and after dilution, of SEK 0.25 (1.63). · Cash flow from continuing operations amounted to SEK 13 million (30). · The acquisition was completed of Internatural AB, a company with a leading position in organic foods in Sweden and Norway, whose brands include Kung

Targovax presents ONCOS-102 scientific rationale at the European Society of Gene and Cell Therapy

Studies to date have shown the ability of ONCOS-102 to immune activate patients with treatment refractory malignant mesothelioma at lesional level  Oslo, 21th October, 2016: Targovax, a clinical stage company focused on developing and commercializing novel immuno-oncology combination therapies, has today presented the scientific rationale for the clinical development of ONCOS-102 in the treatment of malignant mesothelioma at the European Society of Gene and Cell Therapy 2016 in Florence, Italy. Lukasz Kuryk, Senior Research Scientist with Targovax, will review in-vitro, in-vivo and

MSAB: Interim report January – September 2016

Record turnover in the third quarter   Third quarter ·          Net sales increased 20.2 percent to SEK 71.6 (59.6) million (21.9 percent in local currencies) ·          EBIT increased to SEK 23.3 (15.3) million ·          The EBIT margin reached 32.5 (25.7) percent (33.2 percent in local currencies) ·          Profit after tax was SEK 18.3 (12.0) million ·          Earnings per share were SEK 0.99 (0.66) ·          Cash flow from operational activities was SEK 27.5 (14.4) million January - September ·          Net sales increased 5.4 percent to SEK 170.4 (161.

There are no items matching the current filter
There are no more items matching the current filter
Back to top